Penel-Page, Mathilde <br/><br/>
Association of fludarabin, cytarabine, and fractioned gemtuzumab followed by hematopoietic stem cell transplantation for first-line refractory acute myeloid leukemia in children: A single-center experience.  [electronic resource] 

 -  Pediatric blood & cancer  06 2020 
 - e28305 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.28305  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Child<br/>Combined Modality Therapy<br/>Cytarabine--administration & dosage<br/>Drug Resistance, Neoplasm<br/>Female<br/>Follow-Up Studies<br/>Gemtuzumab--administration & dosage<br/>Hematopoietic Stem Cell Transplantation--mortality<br/>Humans<br/>Leukemia, Myeloid, Acute--pathology<br/>Male<br/>Neoplasm Recurrence, Local--pathology<br/>Prognosis<br/>Retrospective Studies<br/>Salvage Therapy<br/>Survival Rate<br/>Vidarabine--administration & dosage